Quantcast

LEH Pharma appoints Sir Henry Riley as Chairman

LEH Pharma, the provider of novel ocular implants for macular disorders, has appointed Sir Henry Riley as Chairman of the Board, ensuring to the company experience in senior management, and a valuable technical expertise. 

Riley was the UK Director and Senior Marketing Advisor for Diehl BGT Defence GmbH, after, among other stops, a thirty year career in the Royal Air Force. Riley was knighted in 2003 for services to industry and is also a Fellow of both the Institute of Engineering and Technology, and the Royal Aeronautical Society.

Dr Bobby Qureshi, CEO and founder of LEH, said that Sir Henry’s significant experience and knowledge are a tremendous asset for LEH Pharma. “I look forward to working closely with him as the Company moves forward,” Qureshi said.

Sir Henry Riley, Chairman of the Board of Directors, said: “LEH Pharma has pioneered the very latest in eye implants for macular degeneration. Through ground-breaking technology and widely accepted techniques, the latest of these products, EyeMax, is transforming the lives of patients with dry and stable wet AMD, which I am pleased to attest to personally. I look forward to the continued rapid growth of the Company and the reach of this brilliant technology.”

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.